No Data
No Data
Icecure Medical Announces It Participated In the American Society Of Breast Surgeons 2025 Annual Meeting On April 30 – May 4, 2025 In Las Vegas Following Recent FDA Development On ProSense Cryoablation
IceCure Medical Announces Meeting With Leadership Of The U.S. Food And Drug Administration's Center For Devices And Radiological Health Regarding The Company's De Novo Marketing Authorization Request For Prosense In The Treatment of Early-Stage Low...
Maxim Group Maintains Icecure Medical(ICCM.US) With Buy Rating, Maintains Target Price $3
Icecure Medical's Growth Potential Highlighted by Clinical Progress and Strategic Financial Position
H.C. Wainwright Maintains Icecure Medical(ICCM.US) With Buy Rating, Maintains Target Price $2.5
IceCure Medical Full Year 2024 Earnings: Misses Expectations